CIITA-driven MHC class II expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells

DOI: 10.1080/2162402X.2016.1261777

Keywords: CD4+ T cells, CIITA, DC, MHC class II

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text